Format
Items per page
Sort by

Send to:

Choose Destination

Results: 1 to 20 of 83

Similar articles for PubMed (Select 23428107)

1.

Medical resource use and costs associated with chylomicronemia.

Gaudet D, Signorovitch J, Swallow E, Fan L, Tremblay K, Brisson D, Meyers C, Gruenberger JB.

J Med Econ. 2013;16(5):657-66. doi: 10.3111/13696998.2013.779277. Epub 2013 Mar 11.

PMID:
23428107
2.

Healthcare costs among patients with chronic constipation: a retrospective claims analysis in a commercially insured population.

Cai Q, Buono JL, Spalding WM, Sarocco P, Tan H, Stephenson JJ, Carson RT, Doshi JA.

J Med Econ. 2014 Feb;17(2):148-58. doi: 10.3111/13696998.2013.860375. Epub 2013 Nov 15.

PMID:
24168640
3.

Clinical comorbidities, treatment patterns, and direct medical costs of patients with osteoarthritis in usual care: a retrospective claims database analysis.

Gore M, Tai KS, Sadosky A, Leslie D, Stacey BR.

J Med Econ. 2011;14(4):497-507. doi: 10.3111/13696998.2011.594347. Epub 2011 Jun 20.

PMID:
21682606
4.

Burden of venous leg ulcers in the United States.

Rice JB, Desai U, Cummings AK, Birnbaum HG, Skornicki M, Parsons N.

J Med Econ. 2014 May;17(5):347-56. doi: 10.3111/13696998.2014.903258. Epub 2014 Mar 24.

PMID:
24625244
5.

Medical costs and healthcare resource use in patients with lupus nephritis and neuropsychiatric lupus in an insured population.

Furst DE, Clarke A, Fernandes AW, Bancroft T, Gajria K, Greth W, Iorga SR.

J Med Econ. 2013;16(4):500-9. doi: 10.3111/13696998.2013.772058. Epub 2013 Feb 11.

PMID:
23363329
6.

Healthcare utilization and cost of systemic lupus erythematosus in a US managed care health plan.

Garris C, Jhingran P, Bass D, Engel-Nitz NM, Riedel A, Dennis G.

J Med Econ. 2013;16(5):667-77. doi: 10.3111/13696998.2013.778270. Epub 2013 Mar 11.

PMID:
23425294
7.

Direct and indirect costs associated with Dupuytren's contracture.

Macaulay D, Ivanova J, Birnbaum H, Sorg R, Skodny P.

J Med Econ. 2012;15(4):664-71. doi: 10.3111/13696998.2012.670678. Epub 2012 Mar 21.

PMID:
22369346
8.

Healthcare utilization and costs of patients with rosacea in an insured population.

Romanowicz M, Stephenson JJ, Del Rosso JQ, Lenhart G.

J Drugs Dermatol. 2008 Jan;7(1):41-9.

PMID:
18246697
9.

Hospital use and medical care costs up to 5 years after triglyceride lowering among patients with severe hypertriglyceridemia.

Nichols GA, Arondekar B, Jacobson TA.

J Clin Lipidol. 2012 Sep-Oct;6(5):443-9. doi: 10.1016/j.jacl.2012.03.002. Epub 2012 Mar 23.

PMID:
23009780
10.

Acute/subacute herpes zoster: healthcare resource utilisation and costs in a group of US health plans.

Insinga RP, Itzler RF, Pellissier JM.

Pharmacoeconomics. 2007;25(2):155-69.

PMID:
17249857
11.

The economic burden of pleural effusions in patients with chronic myeloid leukemia treated with tyrosine kinase inhibitors.

Guérin A, Wu EQ, Bollu VK, Williams D, Guo A, de Leon DP, Quintas-Cardama A.

J Med Econ. 2013;16(1):125-33. doi: 10.3111/13696998.2012.693896. Epub 2012 Jun 6.

PMID:
22587385
12.

Evaluating medical resource utilization and costs associated with thrombocytopenia in chronic liver disease patients.

Poordad F, Theodore D, Sullivan J, Grotzinger K.

J Med Econ. 2012;15(1):112-24. doi: 10.3111/13696998.2011.632463. Epub 2011 Nov 4.

PMID:
21995622
13.
14.

Therapeutic plasma exchange in patients with chylomicronemia syndrome complicated by acute pancreatitis.

Lennertz A, Parhofer KG, Samtleben W, Bosch T.

Ther Apher. 1999 Aug;3(3):227-33.

PMID:
10427620
15.

Patient characteristics and medical care costs associated with hypertriglyceridemia.

Nichols GA, Arondekar B, Garrison LP Jr.

Am J Cardiol. 2011 Jan 15;107(2):225-9. doi: 10.1016/j.amjcard.2010.09.010.

PMID:
21211599
16.

Cost, healthcare resource utilization, and adherence of individuals with diabetes using U-500 or U-100 insulin: a retrospective database analysis.

Eby EL, Wang P, Curtis BH, Xie J, Haldane DC, Idris I, Peters AL, Hood RC, Jackson JA.

J Med Econ. 2013;16(4):529-38. doi: 10.3111/13696998.2013.772059. Epub 2013 Feb 12.

PMID:
23363330
17.

Healthcare resource utilization and direct costs associated with frequent nausea in episodic migraine: results from the American Migraine Prevalence and Prevention (AMPP) Study.

Lipton RB, Buse DC, Saiers J, Serrano D, Reed ML.

J Med Econ. 2013;16(4):490-9. doi: 10.3111/13696998.2013.770748. Epub 2013 Feb 11.

PMID:
23356422
18.

One-year follow-up healthcare costs of patients hospitalized for transient ischemic attack or ischemic stroke and discharged with aspirin plus extended-release dipyridamole or clopidogrel.

Burton TM, Lacey M, Liu F, Yu Y, Monsalvo ML, Lang K, Sander S.

J Med Econ. 2012;15(6):1217-25. doi: 10.3111/13696998.2012.718020. Epub 2012 Aug 17.

PMID:
22857539
19.

Pre-diagnosis excess acute care costs in Alzheimer's patients among a US Medicaid population.

Geldmacher DS, Kirson NY, Birnbaum HG, Eapen S, Kantor E, Cummings AK, Joish VN.

Appl Health Econ Health Policy. 2013 Aug;11(4):407-13. doi: 10.1007/s40258-013-0038-9.

PMID:
23700254
20.

Cost of diabetes: comparison of disease-attributable and matched cohort cost estimation methods.

Tunceli O, Wade R, Gu T, Bouchard JR, Aagren M, Luo W.

Curr Med Res Opin. 2010 Aug;26(8):1827-34. doi: 10.1185/03007995.2010.488544.

PMID:
20491613
Format
Items per page
Sort by

Send to:

Choose Destination

Supplemental Content

Write to the Help Desk